Drug Design, Biomarkers
Biomarkers include tools and technologies that aid in dynamic and powerful approach to understand the spectrum of neurological diseases in knowing the prediction, cause, diagnosis, progression, regression, or outcome of treatment of a disease.
- Track 1-1 Ligand-based Drug Design
- Track 2-2 Structure-based Drug Design
- Track 3-3 Natural History Markers
- Track 4-4 Drug Activity Markers
- Track 5-5 Surrogate/ Diagnostic Biomarkers
- Track 6-6 Molecular Biomarkers